Found 52 matching trials
Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer PHASE2 This is a phase 2, multicenter, single-arm study with a safety lead-in to i...
Show More Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Learn More & Join Trial
Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study NA This study is looking at outcomes in people with advanced cancers who have ...
Show More Location
Peter MacCallum Cancer Centre
Learn More & Join Trial
Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer PHASE2 This phase II trial studies how well encorafenib and binimetinib given with...
Show More Status
Active Not Recruiting
Location
Providence Portland Medical Center
Learn More & Join Trial
Melanoma Metastasized to the Brain and Steroids PHASE2 This clinical trial is to clarify whether treatment with a checkpoint inhib...
Show More Location
Herlev Universityhospital
Learn More & Join Trial
Prognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center Analysis N/A This multicenter, retrospective observational study aims to identify clinic...
Show More Location
Ankara Etlik City Hospital
Learn More & Join Trial
Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases PHASE2 This phase II trial studies the effects of binimetinib and encorafenib in t...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E Mutation PHASE2 This phase II trial studies the side effects and how well the combination o...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Treatment in BRAF V600E Mutated MSS Initially Resectable or Potentially Resectable Advanced Colorectal Cancer PHASE2 As a result of the little benefit obtained from standard treatments and the...
Show More Location
Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD)
Learn More & Join Trial
StrataPATH™ (Precision Indications for Approved Therapies) PHASE2 StrataPATH™ is a non-randomized, open-label trial designed to explore effic...
Show More Location
Florida Cancer Specialists - North
Learn More & Join Trial
Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy PHASE2 The goal of this clinical trial is to investigate adaptive therapy in late-...
Show More Location
Multiple Locations
Learn More & Join Trial